Statement of the Anti-Red Tape Authority on FDA’s Granting of Compassionate Special Permit to a Hospital for use of Ivermectin on Covid-19 patients

The Anti-Red Tape Authority (ARTA) welcomes the move of the Food and Drug Administration (FDA) for granting the application of a hospital for a Compassionate Special Permit to use Ivermectin on humans with COVID-19. With this, ARTA urges FDA to continue processing applications from other medical institutions seeking the same permit expeditiously while key agencies.. read more

ARTA to help PhilHealth resolve slow release of hospital claims

06 April 2021 – To ensure unhampered health services amid the pandemic, the Anti-Red Tape Authority (ARTA) is more than willing to help the Philippine Health Insurance Corporation (PhilHealth) address the backlogs on the release of claims of hospitals. Director General Jeremiah Belgica made the commitment during ARTA’s appearance at the dialogue between PhilHealth and.. read more

ARTA asks FDA to keep their communications open for Ivermectin applications

31 March 2021 – Anti-Red Tape Authority (ARTA) Director General Jeremiah Belgica, in a meeting earlier, called on the Food and Drug Administration (FDA) to “keep their communications open for the registration of pharmaceutical companies who would want to apply for a Drug Emergency Use or a Compassionate Special Permit for Ivermectin”. During the meeting,.. read more